Weiss Ratings reaffirmed their sell (d-) rating on shares of Aurora Cannabis (NASDAQ:ACB – Free Report) in a research report sent to investors on Friday morning,Weiss Ratings reports.
A number of other research analysts have also recently commented on the company. Zacks Research raised Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Wall Street Zen downgraded shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a research note on Friday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy”.
Check Out Our Latest Stock Report on ACB
Aurora Cannabis Stock Up 2.7%
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.37). The company had revenue of $71.98 million for the quarter, compared to the consensus estimate of $96.83 million. Aurora Cannabis had a negative return on equity of 1.49% and a negative net margin of 5.66%. On average, equities research analysts expect that Aurora Cannabis will post 0.46 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of ACB. DKM Wealth Management Inc. acquired a new position in Aurora Cannabis during the second quarter worth about $42,000. JW Asset Management LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter valued at approximately $58,000. Headlands Technologies LLC bought a new stake in shares of Aurora Cannabis during the 2nd quarter valued at approximately $66,000. Engineers Gate Manager LP acquired a new position in Aurora Cannabis during the 2nd quarter worth approximately $68,000. Finally, Silver Oak Securities Incorporated bought a new position in Aurora Cannabis in the 3rd quarter valued at approximately $112,000. Institutional investors own 47.63% of the company’s stock.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
- Five stocks we like better than Aurora Cannabis
- How to Use the MarketBeat Dividend Calculator
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- Using the MarketBeat Dividend Yield Calculator
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Compound Interest and Why It Matters When Investing
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
